2008-2021 年处方药上市价格趋势。
Trends in Prescription Drug Launch Prices, 2008-2021.
机构信息
Program on Regulation, Therapeutics, and Law (PORTAL), Brigham and Women's Hospital, Boston, Massachusetts.
出版信息
JAMA. 2022 Jun 7;327(21):2145-2147. doi: 10.1001/jama.2022.5542.
Abstract
This study uses SSR Health data on drug list prices and estimated net prices after manufacturer discounts to evaluate trends in prices for newly marketed brand-name prescription drugs in the US from 2008 to 2021.
摘要
本研究利用 SSR Health 的药品目录价格数据和制造商折扣后的估计净价格数据，评估了 2008 年至 2021 年美国新上市的品牌处方药价格的趋势。
相似文献
1
Trends in Prescription Drug Launch Prices, 2008-2021.2008-2021 年处方药上市价格趋势。
JAMA. 2022 Jun 7;327(21):2145-2147. doi: 10.1001/jama.2022.5542.
2
Recent Trends in Prescription Drug Launch Prices.处方药上市价格的近期趋势。
JAMA. 2022 Oct 4;328(13):1352. doi: 10.1001/jama.2022.13826.
3
Prescription drug prices in the US.美国的处方药价格。
Med Lett Drugs Ther. 2017 May 22;59(1521):81-83.
4
How to Reduce Prescription Drug Prices: First, Do No Harm.如何降低处方药价格：首先，不要造成伤害。
Mo Med. 2020 Jan-Feb;117(1):14-15.
5
Expensive Medicine: Drug prices are increasingly hard to swallow. Effective remedies prove elusive.昂贵的药物：药品价格越来越让人难以承受。有效的治疗方法却难以寻觅。
Minn Med. 2017 May;100(3):10-17.
6
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.美国处方药价格居高不下：根源与改革前景。
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.
7
Going over the patent cliff.越过专利悬崖。
Minn Med. 2011 Oct;94(10):42-3.
8
Recent Trends in Prescription Drug Launch Prices-Reply.处方药上市价格的近期趋势——回复
JAMA. 2022 Oct 4;328(13):1352-1353. doi: 10.1001/jama.2022.13828.
9
Copayment coupons undermine formularies.共付优惠券破坏了药品处方集。
Manag Care. 2011 Dec;20(12):63.
10
How the US Food and Drug Administration can solve the prescription drug shortage problem.美国食品和药物管理局如何解决处方药短缺问题。
Am J Public Health. 2013 May;103(5):e10-4. doi: 10.2105/AJPH.2013.301239. Epub 2013 Mar 14.
引用本文的文献
1
Changes in Cost of Guideline-Concordant Cancer Treatment: Observations and Implications.符合指南的癌症治疗成本变化：观察与启示
JCO Oncol Pract. 2025 Sep 5:OP2400995. doi: 10.1200/OP-24-00995.
2
Changes in Medicare Part D Plan Designs After the Inflation Reduction Act.《降低通胀法案》出台后医疗保险D部分计划设计的变化。
JAMA Intern Med. 2025 Aug 18. doi: 10.1001/jamainternmed.2025.4003.
3
Advancing the conversation: 30 years of scholarship in managed care pharmacy.推动对话：管理式医疗药学30年学术研究
J Manag Care Spec Pharm. 2025 Jul;31(7):617-626. doi: 10.18553/jmcp.2025.31.7.617.
4
Emerging frontiers in adoptive cell therapies: innovations, challenges, and future perspectives.过继性细胞疗法的新兴前沿领域：创新、挑战与未来展望。
Med Oncol. 2025 Jun 15;42(7):261. doi: 10.1007/s12032-025-02808-z.
5
Trends in Launch Prices and Price Increases for Self-Administered Anticancer Drugs in Medicare.医疗保险中自我给药抗癌药物的上市价格及价格涨幅趋势
JAMA. 2025 May 15. doi: 10.1001/jama.2025.6366.
6
Cost Analysis of Postoperative Medications in a Tertiary Care Hospital in Northeast India.印度东北部一家三级护理医院术后用药的成本分析。
Cureus. 2025 Apr 4;17(4):e81688. doi: 10.7759/cureus.81688. eCollection 2025 Apr.
7
Appraising the visibility, relevance and impacts of clinical pharmacology.评估临床药理学的可见性、相关性及影响。
Br J Clin Pharmacol. 2025 Jul;91(7):1884-1898. doi: 10.1002/bcp.70074. Epub 2025 Apr 27.
8
Understanding social media discourse on antidepressants: unsupervised and sentiment analysis using X.理解社交媒体上关于抗抑郁药的话语：使用X进行无监督和情感分析。
Eur Psychiatry. 2025 Mar 5;68(1):e51. doi: 10.1192/j.eurpsy.2025.10.
9
Exploring the Lack of Transparency in Prescription Drug Costs: Contributors and Avenues for Reform.探索处方药成本缺乏透明度的问题：成因与改革途径
J Gen Intern Med. 2025 Feb 19. doi: 10.1007/s11606-024-09329-x.
10
Evaluation of Biologics ACE2/Ang(1-7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies.评估用于美国食品药品监督管理局（FDA）批准的封装在植物细胞中的生物制剂ACE2/血管紧张素（1-7）：安全性和毒理学研究。
Pharmaceutics. 2024 Dec 25;17(1):12. doi: 10.3390/pharmaceutics17010012.
本文引用的文献
1
Estimating Rebates and Other Discounts Received by Medicare Part D.估算医疗保险处方药部分（Medicare Part D）收到的回扣和其他折扣
JAMA Health Forum. 2021 Jun 4;2(6):e210626. doi: 10.1001/jamahealthforum.2021.0626.
2
National Health Care Spending In 2020: Growth Driven By Federal Spending In Response To The COVID-19 Pandemic.2020 年国家医疗保健支出：联邦支出因应对 COVID-19 大流行而增长。
Health Aff (Millwood). 2022 Jan;41(1):13-25. doi: 10.1377/hlthaff.2021.01763. Epub 2021 Dec 15.
3
An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles.国际药品评估方法及其伦理原则述评
J Law Med Ethics. 2020 Sep;48(3):583-594. doi: 10.1177/1073110520958885.
4
Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.2007-2018 年美国品牌药物的目录价格、净价格和折扣变化。
JAMA. 2020 Mar 3;323(9):854-862. doi: 10.1001/jama.2020.1012.
5
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.美国处方药价格居高不下：根源与改革前景。
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.
Zotero 插件